A panel of experts convened by the Food and Drug Administration voted thirteen to zero that the agency should approve a marijuana-based drug to treat rare forms of epilepsy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,